Publikace
- Novel Approaches in Primary Cardiovascular Disease Prevention: The HOPE-3 Trial Rationale, Design, and Participants' Baseline Characteristics2016 | Publikace bez příslušnosti k fakultě
- Outcomes of patients hospitalized for suspected acute coronary syndrome, in whom the diagnosis was not confirmed: Results from the CZECH-1 and CZECH-2 registries2015 | 1. lékařská fakulta, 3. lékařská fakulta, Lékařská fakulta v Plzni
- Variations in Cause and Management of Atrial Fibrillation in a Prospective Registry of 15 400 Emergency Department Patients in 46 Countries The RE-LY Atrial Fibrillation Registry2014 | Publikace bez příslušnosti k fakultě
- Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome2011 | Publikace bez příslušnosti k fakultě
- Rhythm versus rate control in patients with newly diagnosed atrial fibrillation - Observations from the GARFIELD-AF registry2023 | Publikace bez příslušnosti k fakultě
- Dulaglutide and Incident Atrial Fibrillation or Flutter in patients with type 2 Diabetes; a post-hoc analysis from the REWIND Randomized Trial2022 | Publikace bez příslušnosti k fakultě
- Novel Indices of Cognitive Impairment and Incident Cardiovascular Outcomes in the REWIND Trial2022 | Publikace bez příslušnosti k fakultě
- Dulaglutide and Cardiovascular and Heart Failure Outcomes in Patients With and Without Heart Failure: A Post-hoc Analysis from the REWIND Randomized Trial2022 | Publikace bez příslušnosti k fakultě
- On-treatment Comparative Effectiveness of Vitamin K Antagonists and Direct Oral Anticoagulants in GARFIELD-VTE, and Focus on Cancer and Renal Disease2022 | Publikace bez příslušnosti k fakultě
- Similar cardiovascular outcomes in patients with diabetes and established or high risk for coronary vascular disease treated with dulaglutide with and without baseline metformin2021 | Publikace bez příslušnosti k fakultě
Loading network view...